Targeted R&D Policy Promoting Biotechnology: A Generalized Toolkit for Policymakers - Annexes

Summary

This document includes the annexes from “Targeted R&D Policy Promoting Biotechnology: A Generalized Toolkit for Policymakers” (https://jerusaleminstitute.org.il/en/publications/targeted-rd-policy-promoting-biotechnology-a-generalized-toolkit-for-policymakers/).  The first annex is about the guiding questions for the realist sector assessment.

The second and third annexes

The second is scientific annex which is about the benefits of the TARGET Approach.  Innovative activity will occur naturally to varying degrees in an economy. The degree of this activity will be directly influenced by the commercial capacity to exploit new knowledge, which in turn is affected by investments, commitments and knowledge made previously in the economy which may either fruitfully coincide with an emerging technology or conflict with it. Moreover, because technologies like biotechnology encompass a fairly wide range of applications, the variety of the possible endpoints for the development of a biotechnology sector is equally wide.

The third annex is about stakeholder cooperation.  As discussed above, while the kick-off decision does not necessarily have to be made by the party that will eventually manage the process, it is important that as wide an agreement as possible amongst stakeholders to pursue the strategy is obtained. For policymakers involved, this will involve different steps. This can be described as an identification of the triangle of public sector organizations that may be involved or whose interests overlap (different ministries or agencies), private sector organizations or firms (such as industry bodies, manufacturing concerns, key entrepreneurs or chambers of commerce) and universities. This also includes labour organizations if there is a large industrial presence in the context of the targeted sector in which proposed policies overlap or conflict with their interests.